Insider · CIK 0001528577
Paul Stuka
Files at NSPR (InspireMD, Inc.). First filing Aug 1, 2025, latest May 29, 2026.
In brief
Paul Stuka files SEC Form 4 as director at NSPR (InspireMD, Inc.). Since Aug 1, 2025, Paul Stuka has reported 11 open-market buys worth $334k and 0 open-market sells worth $0, the latest filed on May 29, 2026.
After Paul Stuka's past buys, the stock trailed the S&P 500 by a median 62.5% over six months (n = 6), and 0% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $18k of NSPR on May 27, 2026, filed May 29, 2026, scored 33 (weak). In the last 12 months: 10 buys worth $284k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NSPR: InspireMD, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | NSPRbuy InspireMD, Inc. | $18k 20,000 shares | +3% | 0% from low-68% from high | |
| 48Moderate | InspireMD, Inc. | $17k 15,000 shares | +2% | +6% from low-58% from high | |
| 45Moderate | InspireMD, Inc. | $88k 75,626 shares | +14% | +5% from low-59% from high | |
| 45Moderate | InspireMD, Inc. | $88k 75,626 shares | +14% | +5% from low-59% from high | |
| 43Moderate | InspireMD, Inc. | $9,034 7,895 shares | +2% | +5% from low-58% from high | |
| 23Weak | NSPRbuy InspireMD, Inc. | $4,905 2,710 shares | +1% | +11% from low-51% from high | |
| 28Weak | NSPRbuy InspireMD, Inc. | $9,182 5,073 shares | +1% | +11% from low-51% from high | |
| 28Weak | NSPRbuy InspireMD, Inc. | $9,436 5,073 shares | +1% | +15% from low-49% from high | |
| 28Weak | NSPRbuy InspireMD, Inc. | $19k 10,130 shares | +3% | +18% from low-48% from high | |
| 15Weak | NSPRbuy InspireMD, Inc. | $22k 13,431 shares | +4% | - | |
| 37Weak | InspireMD, Inc. | $50k 20,661 shares | +5% | - |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series J Warrant (right to buy)derivativeindirect: See Footnote | -43,750 | $0.00 | $0 | 43,750 | 20 d ago |
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series J Warrant (right to buy)derivativeindirect: See Footnote | +43,750 | $0.00 | $0 | 43,750 | 20 d ago |
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series K Warrant (right to buy)derivativeindirect: See Footnote | -87,500 | $0.00 | $0 | 0 | 20 d ago |
| Sep 18, 2026 | NSPR InspireMD, Inc. | JOther Series K Warrant (right to buy)derivativeindirect: See Footnote | +87,500 | $0.00 | $0 | 43,750 | 20 d ago |
| May 27, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +20,000 | $0.88 | $18k | 667,871 | May 29, 2026 |
| May 13, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +10,000 | $1.16 | $12k | 642,871 | May 15, 2026 |
| May 14, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +5,000 | $1.15 | $5,750 | 647,871 | May 15, 2026 |
| May 8, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock10b5-1 | +65,626 | $1.16 | $76k | 622,871 | May 13, 2026 |
| May 11, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock10b5-1 | +10,000 | $1.19 | $12k | 632,871 | May 13, 2026 |
| May 8, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock10b5-1 | +65,626 | $1.16 | $76k | 622,871 | May 12, 2026 |
| May 11, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock10b5-1 | +10,000 | $1.19 | $12k | 632,871 | May 12, 2026 |
| May 6, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +1,517 | $1.12 | $1,699 | 525,221 | May 8, 2026 |
| May 7, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +6,378 | $1.15 | $7,335 | 531,599 | May 8, 2026 |
| Dec 9, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +2,710 | $1.81 | $4,905 | 391,628 | Feb 23, 2026 |
| Jan 14, 2026 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +132,076 | $0.00 | $0 | 523,704 | Jan 16, 2026 |
| Dec 9, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +5,073 | $1.81 | $9,182 | 391,628 | Dec 11, 2025 |
| Dec 5, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +5,073 | $1.86 | $9,436 | 388,918 | Dec 8, 2025 |
| Dec 4, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +10,130 | $1.85 | $19k | 383,845 | Dec 5, 2025 |
| Nov 12, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +13,431 | $1.62 | $22k | 373,715 | Nov 13, 2025 |
| Jul 30, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +20,661 | $2.42 | $50k | 444,195 | Aug 1, 2025 |
| Jul 1, 2025 | NSPR InspireMD, Inc. | XIn-the-money exercise Common Stockindirect: See Footnote | +87,500 | $1.38 | $121k | 423,534 | Jul 23, 2025 |
| Jul 1, 2025 | NSPR InspireMD, Inc. | XIn-the-money exercise Series I Warrant (right to buy)derivativeindirect: See Footnote | -87,500 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Common Stock | +48,736 | $0.00 | $0 | 360,284 | Jan 10, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Options to purchase common stock (right to buy)derivative | +22,254 | $0.00 | $0 | 128,129 | Jan 10, 2025 |
Questions about Paul Stuka
Answered from the filings on this page, as of the latest one.
Is Paul Stuka buying or selling?
In the last 12 months Paul Stuka reported 10 open-market buys worth $284k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $18k of NSPR on May 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Paul Stuka's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 62.5% over six months across 6 past buys, with 0% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Paul Stuka file Form 4?
Paul Stuka has filed Form 4 at NSPR (InspireMD, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.